Notably, although rare, pancreatic and stomach cancers are associated with poor prognosis and their incidences have been rising over time, and thus, our results highlight the importance of screening for upper gastrointestinal tract malignancies for BRCA1 and BRCA2 carriers, particularly for age < 65 years. This evidence concerns the gene BRCA2 and gastric cancer.